EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 239 filers reported holding EDITAS MEDICINE INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,462,570 | +122.9% | 187,509 | +135.2% | 0.04% | +117.6% |
| Q2 2023 | $656,203 | +285.3% | 79,733 | +239.4% | 0.02% | +240.0% |
| Q1 2023 | $170,295 | -72.2% | 23,489 | -53.0% | 0.01% | -77.3% |
| Q3 2022 | $612,000 | +30.8% | 49,978 | +183.4% | 0.02% | -24.1% |
| Q4 2021 | $468,000 | -57.9% | 17,634 | -33.4% | 0.03% | -71.6% |
| Q1 2021 | $1,112,000 | +321.2% | 26,467 | +181.7% | 0.10% | +500.0% |
| Q3 2020 | $264,000 | +11.9% | 9,394 | +17.5% | 0.02% | +6.2% |
| Q2 2020 | $236,000 | -36.7% | 7,993 | -47.6% | 0.02% | -38.5% |
| Q1 2019 | $373,000 | -83.0% | 15,242 | -84.2% | 0.03% | -81.0% |
| Q4 2018 | $2,193,000 | +356.9% | 96,411 | +538.5% | 0.14% | +280.6% |
| Q3 2018 | $480,000 | -70.0% | 15,100 | -68.7% | 0.04% | -67.9% |
| Q1 2018 | $1,600,000 | +240.4% | 48,265 | +146.8% | 0.11% | -5.1% |
| Q3 2017 | $470,000 | -13.3% | 19,556 | -19.5% | 0.12% | +68.6% |
| Q1 2017 | $542,000 | – | 24,303 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |